Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Biochem Pharmacol. 2021 Feb 3;189:114453. doi: 10.1016/j.bcp.2021.114453

Figure 7.

Figure 7.

(A) Cryo-section of EGFP expression in tumor observed under CLSM after treatment with negative control, EGFP/PEI25K polyplexes and EGFP/PMet-P(cdmPEG2K) micelleplexes for 24 h in 4T1.2 tumor-bearing mice (EGFP dose: 25 μg/mice). Negative control represents mice treated only with Hoechst 33342. (B) Quantification of the percentage of GFP positive cells by Image J.